Joincare Pharmaceutical Group Industry Co.,Ltd.

SHSE:600380 Rapporto sulle azioni

Cap. di mercato: CN¥22.2b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Joincare Pharmaceutical Group IndustryLtd Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Xiong Yu

Amministratore delegato

CN¥3.6m

Compenso totale

Percentuale dello stipendio del CEO72.2%
Mandato del CEOno data
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

May 31
Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

Recent updates

Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market

Aug 13
Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market

We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Jun 23
We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease

Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

May 31
Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being

Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings

Apr 09
Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings

Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel

Mar 04
Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Xiong Yu rispetto agli utili di Joincare Pharmaceutical Group IndustryLtd?
DataCompenso totaleStipendioGuadagni aziendali
Jun 30 2024n/an/a

CN¥1b

Mar 31 2024n/an/a

CN¥1b

Dec 31 2023CN¥4mCN¥3m

CN¥1b

Sep 30 2023n/an/a

CN¥1b

Jun 30 2023n/an/a

CN¥2b

Mar 31 2023n/an/a

CN¥2b

Dec 31 2022CN¥4mCN¥3m

CN¥2b

Sep 30 2022n/an/a

CN¥1b

Jun 30 2022n/an/a

CN¥1b

Mar 31 2022n/an/a

CN¥1b

Dec 31 2021CN¥3mCN¥2m

CN¥1b

Compensazione vs Mercato: La retribuzione totale di Xiong ($USD 504.91K ) è superiore alla media delle aziende di dimensioni simili nel mercato CN ($USD 225.96K ).

Compensazione vs guadagni: La retribuzione di Xiong è stata coerente con le performance aziendali dell'ultimo anno.


AMMINISTRATORE DELEGATO

Xiong Yu (63 yo)

no data

Mandato

CN¥3,600,000

Compensazione

Mr. Xiong Yu serves as Non-Executive Director of Livzon Pharmaceutical Group Inc. since June 30, 2020. He serves as the Deputy Vice-President and a Researcher of China State Institute of Pharmaceutical Ind...